The Wuhan Institute of Virology has developed a nasal nanovaccine designed to offer broad protection against major COVID-19 variants and potential future mutations. Combining ferritin with coronavirus epitopes to trigger immune responses, this new vaccine has shown promise in early studies against strains such as Delta, Omicron, and the original Wuhan strain.
Is China’s Wuhan lab getting ready for another outbreak?
Posted on by satyavallam
You May Also Like
Top 10 countries with good work-life balance
November 8, 2024
Severe health issues in Delhi’s most polluted area
November 8, 2024
Personality test: Are you humble or competitive?
November 8, 2024